These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 3489461

  • 1. Interactions of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidases.
    Singer TP, Salach JI, Castagnoli N, Trevor A.
    Biochem J; 1986 May 01; 235(3):785-9. PubMed ID: 3489461
    [Abstract] [Full Text] [Related]

  • 2. Reversible inhibition and mechanism-based irreversible inactivation of monoamine oxidases by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Singer TP, Salach JI, Crabtree D.
    Biochem Biophys Res Commun; 1985 Mar 15; 127(2):707-12. PubMed ID: 3872126
    [Abstract] [Full Text] [Related]

  • 3. Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP.
    Salach JI, Singer TP, Castagnoli N, Trevor A.
    Biochem Biophys Res Commun; 1984 Dec 14; 125(2):831-5. PubMed ID: 6335034
    [Abstract] [Full Text] [Related]

  • 4. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T, Arán VJ, Guillén H.
    Free Radic Res; 2009 Oct 14; 43(10):975-84. PubMed ID: 19669997
    [Abstract] [Full Text] [Related]

  • 5. Processing of MPTP by monoamine oxidases: implications for molecular toxicology.
    Trevor AJ, Singer TP, Ramsay RR, Castagnoli N.
    J Neural Transm Suppl; 1987 Oct 14; 23():73-89. PubMed ID: 3295117
    [Abstract] [Full Text] [Related]

  • 6. Studies on the 1-methyl-4-phenyl-2,3-dihydropyridinium species 2,3-MPDP+, the monoamine oxidase catalyzed oxidation product of the nigrostriatal toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Peterson LA, Caldera PS, Trevor A, Chiba K, Castagnoli N.
    J Med Chem; 1985 Oct 14; 28(10):1432-6. PubMed ID: 3876442
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK, Sonsalla PK, Sieber BA, Heikkila RE.
    J Pharmacol Exp Ther; 1989 Jun 14; 249(3):820-8. PubMed ID: 2786564
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B.
    Fritz RR, Abell CW, Patel NT, Gessner W, Brossi A.
    FEBS Lett; 1985 Jul 08; 186(2):224-8. PubMed ID: 3874094
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 1-Methyl-4-phenyl-2,3-dihydropyridinium is transformed by ubiquinone to the selective nigrostriatal toxin 1-methyl-4-phenylpyridinium.
    Shi H, Noguchi N, Xu Y, Niki E.
    FEBS Lett; 1999 Nov 19; 461(3):196-200. PubMed ID: 10567696
    [Abstract] [Full Text] [Related]

  • 14. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine- and 1-methyl-4-(2'-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced toxicity in PC12 cells: role of monoamine oxidase A.
    Basma AN, Heikkila RE, Nicklas WJ, Giovanni A, Geller HM.
    J Neurochem; 1990 Sep 19; 55(3):870-7. PubMed ID: 2384758
    [Abstract] [Full Text] [Related]

  • 15. Bioactivation of MPTP: reactive metabolites and possible biochemical sequelae.
    Trevor AJ, Castagnoli N, Caldera P, Ramsay RR, Singer TP.
    Life Sci; 1987 Feb 23; 40(8):713-9. PubMed ID: 3492651
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mechanism-based inactivation of monoamine oxidases A and B by tetrahydropyridines and dihydropyridines.
    Krueger MJ, McKeown K, Ramsay RR, Youngster SK, Singer TP.
    Biochem J; 1990 May 15; 268(1):219-24. PubMed ID: 2344359
    [Abstract] [Full Text] [Related]

  • 19. Participation of brain monoamine oxidase B form in the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: relationship between the enzyme inhibition and the neurotoxicity.
    Kinemuchi H, Arai Y, Toyoshima Y.
    Neurosci Lett; 1985 Jul 31; 58(2):195-200. PubMed ID: 3876524
    [Abstract] [Full Text] [Related]

  • 20. Inactivation of monoamine oxidase by 3,3-dimethyl analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-2,3-dihydropyridinium ion. Dramatic effect of beta-mercaptoethanol on substrate turnover and enzyme inactivation.
    Hiebert CK, Sayre LM, Silverman RB.
    J Biol Chem; 1989 Dec 25; 264(36):21516-21. PubMed ID: 2600079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.